国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01099 国药控股

已收盘 03-25 16:08:32

20.100

+0.420

+2.13%

最高20.240	最低19.720	成交量801.31万
今开19.880	昨收19.680	日振幅2.64%
总市值627.32亿	流通市值269.70亿	总股本31.21亿
成交额1.60亿	换手率0.60%	流通股本13.42亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"国药控股","latestPrice":20.1,"timestamp":1774426112002,"preClose":19.68,"halted":0,"volume":8013086,"delay":0,"changeRate":0.021341463414634235,"floatShares":1341810740,"shares":3121000000,"eps":2.259128,"marketStatus":"已收盘","change":0.42,"latestTime":"03-25 16:08:32","open":19.88,"high":20.24,"low":19.72,"amount":159756309,"amplitude":0.026423,"askPrice":20.1,"askSize":112800,"bidPrice":20.08,"bidSize":2400,"shortable":3,"etf":0,"ttmEps":2.479965,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774488600000},"marketStatusCode":5,"adr":0,"listingDate":1253635200000,"exchange":"SEHK","adjPreClose":19.68,"dividendRate":0.036736,"openAndCloseTimeList":[[1774402200000,1774411200000],[1774414800000,1774425600000]],"volumeRatio":1.209906,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK","impliedVol":0.3235,"impliedVolPercentile":0.9228},"requestUrl":"/m/hq/s/01099","defaultTab":"news","newsList":[{"id":"2622047303","title":"【券商聚焦】华泰研究维持国药控股(01099)“买入”评级 指零售板块领衔增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2622047303","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622047303?lang=zh_cn&edition=full","pubTime":"2026-03-25 14:31","pubTimestamp":1774420277,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰研究发布研报指，国药控股 2025年收入为5752亿元人民币，同比下降1.6%，归母净利润为71.6亿元，同比增长1.5%，符合市场预期。展望2026年，随着药品及器械分销业务结构持续优化带动收入企稳，零售板块批零协同深化经营改善，预计公司净利润将继续保持正增长。零售业务2025年收入为384亿元，同比增长6.67%，成为集团领衔增长的板块，经营溢利率提升0.66个百分点至1.56%，主要得益于整体降本增效的费用管控及国大药房显著减亏。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200915/NjdlOTQyZDE5NzA3MzU4ZTU3YTk2ZGQ0MjAwMDE4NjcyODIz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NjdlOTQyZDE5NzA3MzU4ZTU3YTk2ZGQ0MjAwMDE4NjcyODIz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977210","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0},{"id":"2621550420","title":"瑞银：微升国药控股(01099)目标价至25.7港元 预料今年收入增长胜同行","url":"https://stock-news.laohu8.com/highlight/detail?id=2621550420","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621550420?lang=zh_cn&edition=full","pubTime":"2026-03-24 14:30","pubTimestamp":1774333840,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研报称，国药控股(01099)2025年总收入5,751亿元人民币(下同)，同比跌1.6%；股东应占净利润71.6亿元，同比升1.5%，均大致符预期。行业政策逆风持续对分销收入构成压力，但该行认为公司的成本控制和业务优化降低了营运费用率。该行上调2026至2028年每股盈利预测1%至2%，维持“买入”评级，目标价由24.2港元上调至25.7港元。该行预期，公司今年收入增长将快于行业，主要受惠于市场份额提升、创新药分销业务及零售业务，净利润率有望轻微扩张。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01099"],"gpt_icon":0},{"id":"2621037229","title":"港股异动 | 国药控股(01099)跌近5% 去年纯利同比增长1.5% 花旗微降公司目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2621037229","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621037229?lang=zh_cn&edition=full","pubTime":"2026-03-24 11:49","pubTimestamp":1774324198,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国药控股跌近5%，截至发稿，跌4.8%，报19.44港元，成交额5621.42万港元。消息面上，国药控股发布2025年度业绩，该集团取得收入人民币5751.68亿元，同比减少1.6%；母公司持有者应占溢利71.55亿元，同比增加1.5%；每股盈利2.29元，拟派发末期股息每股0.69元。花旗发布研报称，国药控股管理层在业绩会议上预期，今年药品分销业务销售额同比持平，医疗器械分销及零售业务则预期进一步复苏，录得正增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01099","VXUS"],"gpt_icon":0},{"id":"1162249749","title":"异动解读 | 花旗下调目标价及业绩指引偏谨慎，国药控股盘中大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162249749","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162249749?lang=zh_cn&edition=full","pubTime":"2026-03-24 10:36","pubTimestamp":1774319797,"startTime":"0","endTime":"0","summary":"国药控股今日盘中大跌5.04%，股价创下近期新低，引发市场关注。消息面上，花旗发布报告，将国药控股的目标价从23港元下调至22.8港元。同时，在公司业绩发布后的会议上，管理层对2026年的业务展望给出了指引，其中药品分销业务的销售额预计将同比持平，而器械分销和零售业务则预计将进一步复苏，实现同比正增长。分析认为，花旗下调目标价以及管理层对核心药品分销业务增长持平的预期，可能是导致投资者信心受挫、股价在交易时段内承压下跌的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01099"],"gpt_icon":0},{"id":"2621095723","title":"【券商聚焦】交银国际：CXO行情持续回暖 料板块估值倍数合理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095723","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621095723?lang=zh_cn&edition=full","pubTime":"2026-03-23 10:25","pubTimestamp":1774232735,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，多重利好因素共振下，2025年以来CXO行情持续回暖。该机构建议重点关注标的细分赛道成长力、核心能力布局、盈利和订单增长能见度、地缘风险敞口及估值上升空间。基于此，该机构首推药明合联，首次覆盖并重点推荐凯莱英和康龙化成。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0540923850.HKD","IE00B543WZ88.USD","BK1593","LU1770034418.SGD","09926","LU0307460666.USD","LU0348767384.USD","LU2399975544.HKD","BK1583","LU2476274308.USD","CXO","LU0417516902.SGD","LU0634319403.HKD","LU0348784397.USD","LU1719994722.HKD","LU2328871848.SGD","02367","BK1585","BK1588","BK1197","BK1500","06160","IE00BPRC5H50.USD","03933","09688","LU0348766576.USD","LU0417516571.SGD","BK1191","01789","BK1207","LU0348735423.USD","06821","LU2778985437.USD","LU1115378108.SGD","LU0348827113.USD","02228","LU2488822045.USD","LU1794554557.SGD","01530","BK1141","LU0417516738.SGD","BK1574","03329","02196","BK1617","LU1303224171.USD","01099","02268","LU2476274720.SGD"],"gpt_icon":0},{"id":"2621554742","title":"国药控股(01099)发布年度业绩，归母净利润71.55亿元 同比增加1.5% 末期股息每股0.69元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621554742","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621554742?lang=zh_cn&edition=full","pubTime":"2026-03-23 07:17","pubTimestamp":1774221459,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药控股 发布截至2025年12月31日止年度业绩，该集团取得收入人民币5751.68亿元，同比减少1.6%;母公司持有者应占溢利71.55亿元，同比增加1.5%;每股盈利2.29元，拟派发末期股息每股0.69元。报告期内，经营性现金流实现净流入为141.38亿元，较上年同期多流入25.92亿元，现金流管理成效突出;应收账款增幅显著收窄，应收账款专项治理显效;资产负债率同比下降2.12个百分点。报告期内，三大主营业务板块延续差异化发展态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01099","VIG"],"gpt_icon":0},{"id":"1121922826","title":"国药控股将于2026年8月18日派发末期股息每股0.69元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121922826","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121922826?lang=zh_cn&edition=full","pubTime":"2026-03-23 06:22","pubTimestamp":1774218127,"startTime":"0","endTime":"0","summary":"国药控股(01099)\n2026年3月20日，公司公告拟派发截至2025年12月31日止年度的末期股息，每股人民币0.69元，待2026年6月18日股东大会审议通过后正式派发。公司预设以港币进行派息，具体金额及汇率尚未公布。\n根据公告，除净日定于2026年6月23日，股东如欲享有股息派发，须在2026年6月24日16:30前递交过户文件。股份过户登记将于2026年6月25日至6月30日暂停办理，2026年6月30日为记录日期。股息派发日为2026年8月18日。\n公告同时披露了适用于非居民企业、非个人民事主体及港股通等不同类型投资者的代扣所得税税率安排，最高预扣税率为20%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0},{"id":"1187221455","title":"国药控股2025年度营收524.68亿元，净利润19.71亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187221455","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187221455?lang=zh_cn&edition=full","pubTime":"2026-03-19 21:43","pubTimestamp":1773927789,"startTime":"0","endTime":"0","summary":"本季度信息\n国药控股（股票代码：01099）公布2025年度财报。财报显示，公司在报告期内实现营收52,468,280,576.72元，同比增长3.70%。同期，公司扣除非经常性损益后的净利润为1,970,533,716.86元，同比下降1.28%。财报同时显示，经营活动产生的现金流量净额达到2,005,517,512.06元，同比上升20.88%。整体来看，公司业务规模稳步提升，盈利能力保持相对稳定。\n业务分项\n高管解读","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0},{"id":"2620225019","title":"国药控股(01099)：国药器械年度营业利润12.49亿元 同比增加2.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225019","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620225019?lang=zh_cn&edition=full","pubTime":"2026-03-19 21:36","pubTimestamp":1773927365,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药控股(01099)发布公告，本公司附属公司中国医疗器械有限公司(国药器械)截至2025年12月31日止年度取得营业收入748.93亿元，同比减少2.35%;营业利润12.49亿元，同比增加2.38%;归属于母公司所有者的综合收益5.07亿元，同比增加25.64%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1500","01099","LU0640798160.USD","BK1197","LU1115378108.SGD"],"gpt_icon":0},{"id":"1182437015","title":"国药控股(01099)2025年度营收748.93亿元，经调整净利润5.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182437015","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182437015?lang=zh_cn&edition=full","pubTime":"2026-03-19 21:31","pubTimestamp":1773927072,"startTime":"0","endTime":"0","summary":"本年度信息\n国药控股(01099)发布的最新财报显示，2025年度公司营收为748.93亿元，同比下降2.35%。同期，经调整后净利润为5.07亿元，同比增长25.64%。经营利润为12.49亿元，经营利润率约为1.67%，相比上年同期略有提升。\n经营活动产生的现金流量净额为7.39亿元，去年同期为-13.56亿元。本期末，公司总资产达573.02亿元，同比下降7.07%；归属于母公司所有者权益合计为83.00亿元，同比增长5.27%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0},{"id":"1191540618","title":"国药控股(01099)2025年度营收734.16亿元，经调整净利润109.57亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191540618","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191540618?lang=zh_cn&edition=full","pubTime":"2026-03-18 06:16","pubTimestamp":1773785800,"startTime":"0","endTime":"0","summary":"根据公告披露，国药控股旗下国药集团一致药业股份有限公司在截至2025年12月31日止年度实现营业收入734.16亿元，同比下降1.29%。经营利润达到15.13亿元，同比增幅163.80%。经调整后归属于上市公司股东的净利润为109.57亿元，同比上涨88.53%。公告指出，报告期内利润增长主要由于商誉及无形资产减值计提同比减少，以及人力与租金等刚性费用随门店调整而下降所致。公告提及，2026年是“十五五”规划的开局之年，亦是国药一致深化转型、迈向高质量发展的关键时期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0},{"id":"2619166690","title":"国药控股获摩根大通增持74.98万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619166690","media":"和讯网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619166690?lang=zh_cn&edition=full","pubTime":"2026-03-12 22:05","pubTimestamp":1773324303,"startTime":"0","endTime":"0","summary":"格隆汇3月12日丨根据联交所最新权益披露资料显示，2026年3月9日，国药控股(01099.HK)获JPMorgan Chase & Co.以每股均价20.4501港元增持好仓74.98万股，涉资约1533.32万港元。增持后，JPMorgan Chase & Co.最新持好仓数目为6767.56万股，持好仓比例由4.98%上升至5.04%。本文来自和讯财经，更多精彩资讯请下载“和讯财经”APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312220754954a8972&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312220754954a8972&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","BK1515","LU0640798160.USD","BK1500","LU1115378108.SGD","01099"],"gpt_icon":0},{"id":"2619669581","title":"国药控股03月12日获主力加仓1372.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619669581","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619669581?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:15","pubTimestamp":1773303328,"startTime":"0","endTime":"0","summary":"03月12日, 国药控股股价涨1.25%，报收21.06元，成交金额1.5亿元，换手率0.54%，振幅2.88%，量比1.22。国药控股今日主力资金净流入1372.6万元，上一交易日主力净流入2310.1万元。近一年数据显示，该股主力连续10日净流入后，次日上涨概率为50.00%，平均涨幅为0.98%。该股近5个交易日下跌0.87%，主力资金累计净流入6325.0万元；近20日主力资金累计净流入2.0亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312161645a6ba4121&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312161645a6ba4121&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","01099","LU0640798160.USD","BK1500","BK1197","BK1515"],"gpt_icon":0},{"id":"2618794041","title":"每日卖空追踪 | 国药控股 03月11日卖空量成交64.84万股，卖空比例为17.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618794041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618794041?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217819,"startTime":"0","endTime":"0","summary":"国药控股北京时间03月11日，跌0.67%，卖空量成交64.84万股，较上一交易日减少66.07%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163209a460b50d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163209a460b50d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","LU0640798160.USD","01099","BK1515","BK1197","BK1500"],"gpt_icon":0},{"id":"2618934236","title":"Lazard Asset Management LLC增持国药控股(01099)363.72万股 每股作价约20.63港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618934236","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618934236?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:54","pubTimestamp":1773140062,"startTime":"0","endTime":"0","summary":"据香港联交所最新数据显示，3月4日，Lazard Asset Management LLC增持国药控股(01099)363.72万股，每股作价20.6296港元，总金额约为7503.4万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260310/20260310185456_19864.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260310/20260310185456_19864.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lazard Asset Management LLC增持国药控股(01099)363.72万股 每股作价约20.63港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01099","BK1197","LU0640798160.USD","LU1115378108.SGD","BK1500","BK1515"],"gpt_icon":0},{"id":"2618933906","title":"国药控股(01099.HK)3月20日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2618933906","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618933906?lang=zh_cn&edition=full","pubTime":"2026-03-10 17:07","pubTimestamp":1773133624,"startTime":"0","endTime":"0","summary":"格隆汇3月10日丨国药控股(01099.HK)宣布，将于2026年3月20日(星期五)举行董事会会议，藉以考虑及批准(其中包括)公司及其附属公司截至2025年12月31日止十二个月之年度业绩及宣派股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260310/32057367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1115378108.SGD","BK1197","LU0640798160.USD","BK1515","BK1500","01099"],"gpt_icon":0},{"id":"2617919503","title":"【券商聚焦】交银国际：医药公司业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617919503","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617919503?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:08","pubTimestamp":1772759313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，2026年以来，内资通过港股通持有医药股的比例呈现先降后升态势，当前水平与年初持平，外资持仓则有所提升。本周内资继续加仓创新药产业链和器械标的，外资则重点布局创新药企及CXO企业。年报季临近，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976027","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","159938","BK1515","LU0348825331.USD","LU2476274308.USD","BK1207","LU0348735423.USD","LU0540923850.HKD","LU2488822045.USD","HK0000165453.HKD","01789","09688","LU2399975544.HKD","BK1191","SG9999004311.SGD","09939","BK1141","LU1719994722.HKD","LU0348784397.USD","IE00BPRC5H50.USD","LU1303224171.USD","LU2778985437.USD","09926","IE00B5MMRT66.SGD","LU0348783233.USD","LU1794554557.SGD","BK1585","02228","LU0561508036.HKD","LU1961090484.USD","03933","LU0348827113.USD","LU0640798160.USD","LU0417516571.SGD","LU2476274720.SGD","01530","LU1115378108.SGD","02367","LU1770034418.SGD","02196","BK1197","BK1593","LU2328871848.SGD","SG9999014674.SGD","LU0588546209.SGD","LU0348766576.USD","BK1574","01099","03329","02268"],"gpt_icon":0},{"id":"2617654515","title":"每日卖空追踪 | 国药控股 03月05日卖空量成交78.76万股，卖空比例为15.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617654515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617654515?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699419,"startTime":"0","endTime":"0","summary":"国药控股北京时间03月05日，涨0.19%，卖空量成交78.76万股，较上一交易日减少68.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163210a44ef5df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163210a44ef5df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","BK1515","LU0640798160.USD","01099","BK1500","LU1115378108.SGD"],"gpt_icon":0},{"id":"2617545146","title":"国药控股2026年2月法定/注册股本及已发行股份无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2617545146","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617545146?lang=zh_cn&edition=full","pubTime":"2026-03-05 06:20","pubTimestamp":1772662849,"startTime":"0","endTime":"0","summary":"金吾财讯|国药控股股份有限公司于2026年3月5日向香港交易及结算所有限公司提交了截至2026年2月28日的股份变动月报表。在已发行股份及库存股份变动方面，H股和内资股的已发行股份数目和库存股份数目均未发生变化，H股已发行股份总数为1,341,810,740，内资股已发行股份总数为1,778,845,451。此外，公告确认公司已符合适用的公众持股量要求，无需进行股份回购或其他变动。本次公告显示，国药控股在2026年2月的股本结构保持稳定，未发生任何变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305063348a44cc183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305063348a44cc183&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU1115378108.SGD","BK1197","BK1500","LU0640798160.USD","01099"],"gpt_icon":0},{"id":"1110825667","title":"国药控股（01099）2月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1110825667","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110825667?lang=zh_cn&edition=full","pubTime":"2026-03-05 06:20","pubTimestamp":1772662828,"startTime":"0","endTime":"0","summary":"国药控股于2026年3月5日发布截至2026年2月28日的股份变动月报。公告显示，公司于本报告期内的已发行股份总数维持不变，无新增发行、购回或注销等变动。\n根据公告，国药控股当前注册股本由H股与内资股两部分构成，H股为1,341,810,740股，内资股为1,778,845,451股，总计3,120,656,191股。本月未见期权或股权激励计划方面的授出、行使或失效等调整。\n公司声明已达到并符合香港联交所对公众持股量比例的相关要求。该份月报由公司秘书吴壹建签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":-0.0708},{"period":"1month","weight":-0.062},{"period":"3month","weight":0.0077},{"period":"6month","weight":0.0713},{"period":"1year","weight":0.0899},{"period":"ytd","weight":0.0123}],"compareEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":-0.0511},{"period":"3month","weight":-0.0293},{"period":"6month","weight":-0.0537},{"period":"1year","weight":0.0484},{"period":"ytd","weight":-0.0221}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.004643},{"month":2,"riseRate":0.588235,"avgChangeRate":0.029413},{"month":3,"riseRate":0.470588,"avgChangeRate":0.005561},{"month":4,"riseRate":0.4375,"avgChangeRate":0.022869},{"month":5,"riseRate":0.625,"avgChangeRate":-0.004548},{"month":6,"riseRate":0.4375,"avgChangeRate":-0.005852},{"month":7,"riseRate":0.5,"avgChangeRate":-0.015111},{"month":8,"riseRate":0.4375,"avgChangeRate":0.012101},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.011177},{"month":10,"riseRate":0.647059,"avgChangeRate":0.042295},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.007287},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.004122}],"exchange":"SEHK","name":"国药控股","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股,01099,国药控股股票,国药控股股票老虎,国药控股股票老虎国际,国药控股行情,国药控股股票行情,国药控股股价,国药控股股市,国药控股股票价格,国药控股股票交易,国药控股股票购买,国药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}